References
  1. Baj J, Karakuła-Juchnowicz H, Teresiński G, Buszewicz G, Ciesielka M, Sitarz E, et al. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. J Clin Med. 2020 Jun 5;9(6):1753.
  2. Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020 Oct 23;371:m3862.
  3. Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020 Jun;80(6):656-665.
  4. Wang L, Wang Y, Ye D, Liu Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents. 2020 Jun;55(6):105948.
  5. Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, et al. Asian Critical Care Clinical Trials Group. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020 May;8(5):506-517.
  6. Kocyigit BF, Akyol A. Reactive arthritis after COVID-19: a case-based review. Rheumatol Int. 2021 Nov;41(11):2031-2039.
  7. Camargo-Martínez W, Lozada-Martínez I, Escobar-Collazos A, Navarro-Coronado A, Moscote-Salazar L, Pacheco-Hernández A, et al. Post-COVID 19 neurological syndrome: Implications for sequelae’s treatment. J Clin Neurosci. 2021 Jun;88:219-225.
  8. Ahmed S, Zimba O, Gasparyan AY. COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol . 2021;40(7):2611-2619.
  9. Karaarslan F, Demircioğlu Güneri F, Kardeş S. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews. Rheumatol Int. 2021 Jul;41(7):1263-1271.
  10. Carroll E, Neumann H, Aguero-Rosenfeld ME, Lighter J, Czeisler BM, Melmed K, et al. Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus. Epilepsia. 2020 Oct;61(10):e135-e139.
  11. Maideniuc C, Memon AB. RETRACTED ARTICLE: Acute necrotizing myelitis and acute motor axonal neuropathy in a COVID-19 patient. J Neurol. 2021 Feb;268(2):739.
  12. Jovani V, Pascual E, Vela P, Andrés M. Acute arthritis following SARS-CoV-2 infection. J Med Virol. 2021 Feb;93(2):661.
  13. Marks M, Marks JL. Viral arthritis. Clin Med (Lond). 2016 Apr;16(2):129-34.
  14. Colatutto D, Sonaglia A, Zabotti A, Cereser L, Girometti R, Quartuccio L. Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature. Viruses. 2021 Aug 6;13(8):1558.
  15. Joob B, Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol. 2020 May;82(5):e177.
  16. Sinaei, R, Pezeshki, S, Parvaresh, S, Sinaei R, Shiari R, Hassas Yeganeh M, et al. Post SARS-CoV-2 infection reactive arthritis: a brief report of two pediatric cases. Pediatr Rheumatol Online J. 2021 Jun 12;19(1):89.
  17. Lahu A, Backa T, Ismaili J, Lahu V, Saiti V. Modes of presentation of reactive arthritis based on the affected joints. Med Arch. 2015 Feb;69(1):42-5.
  18. Gibson M, Sampat K, Coakley G.A self-limiting symmetrical polyarthritis following COVID-19 infection. Rheumatol Adv Pract . 2020;4(1):052.014.
  19. Mukarram IG, Mukarram MS, Ishaq K, Riaz SU .Post COVID-19 Reactive Arthritis: An Emerging Existence in the Spectrum of Musculoskeletal Complications of SARS-CoV-2 Infection. J Clin Stud Med Case Rep.2020 ;7: 0101.
  20. Bentaleb I, Abdelghani KB, Rostom S, Amine B, Laatar A, Bahiri R. Reactive Arthritis: Update. Curr Clin Microbiol Rep. 2020 Sep 26:1-9.
  21. Talarico R, Stagnaro C, Ferro F, Carli L, Mosca M. Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection. Lancet Rheumatol. 2020 Sep;2(9):e518-e519.
  22. Qaiyum Z, Lim M, Inman RD. The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights. Semin Immunopathol. 2021 Apr;43(2):173-192.
  23. Halpert G, Shoenfeld Y. SARS-CoV-2, the autoimmune virus. Autoimmun Rev. 2020 Dec;19(12):102695.
  24. Hwa KY, Lin WM, Hou YI, Yeh TM. Peptide mimicrying between SARS coronavirus spike protein and human proteins reacts with SARS patient serum. J Biomed Biotechnol. 2008;2008:326464.
  25. Gasparotto M, Framba V, Piovella C, Doria A, Iaccarino L. Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol. 2021 Aug;40(8):3357-3362.
  26. Kim B, Kaistha SD, Rouse BT. Viruses and autoimmunity. Autoimmunity. 2006 Feb;39(1):71-7.
  27. Cappello F. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? Cell Stress Chaperones. 2020 May;25(3):381-382.
  28. Angileri F, Legare S, Marino Gammazza A, Conway de Macario E, Jl Macario A, Cappello F. Molecular mimicry may explain multi-organ damage in COVID-19. Autoimmun Rev. 2020 Aug;19(8):102591.
  29. Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020 Jun 25;382(26):2574-2576.
  30. Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Mañas R, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020 Aug 4;95(5):e601-e605.
  31. Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, et al. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 2021 Apr 18;13(4):700.
  32. Zacharias H, Dubey S, Koduri G, D’Cruz D. Rheumatological complications of Covid 19. Autoimmun Rev. 2021 Sep;20(9):102883.
  33. Ibáñez S, Martínez O, Valenzuela F, Silva F, Valenzuela O. Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy? Clin Rheumatol. 2020 Aug;39(8):2461-2465.
  34. Parisi S, Borrelli R, Bianchi S, Fusaro E. Viral arthritis and COVID-19. Lancet Rheumatol. 2020 Nov;2(11):e655-e657.
  35. Baimukhamedov C, Barskova T, Matucci-Cerinic M. Arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021 May;3(5):e324-e325.
  36. Alivernini S, Cingolani A, Gessi M, et al. Comparative analysis of synovial inflammation after SARS-CoV-2 infection. Ann Rheum Dis. 2020 Jul 6:annrheumdis-2020-218315.